Source link : https://www.newshealth.biz/health-news/medicare-cancer-drug-costs-not-linked-to-clinical-value/
TOPLINE: A new analysis suggests that Medicare spending on anticancer drugs is not based on a drug’s clinical value, highlighting “a misalignment between drug pricing and the clinical benefits they offer.” METHODOLOGY: Medicare typically accepts the drug prices set by the manufacturer, instead of negotiating drug prices like many other countries do. As a result, […]
Author : News Health
Publish date : 2025-01-17 08:33:00
Copyright for syndicated content belongs to the linked Source.